CNS Pharmaceuticals, Inc. · NASDAQ:CNSP

CNS Pharmaceuticals, Inc. shareholders

As of Sep 30, 2026, 12 institutions reported holding CNS Pharmaceuticals, Inc., 20.7% of its shares. Largest: Ikarian Capital, LLC, ADAR1 Capital Management, LLC and Stonepine Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of CNS Pharmaceuticals, Inc.ChangeFiled
Ikarian Capital, LLC136K9.2%no changeNov 16, 2026
ADAR1 Capital Management, LLC70,0004.7%no changeNov 16, 2026
Stonepine Capital Management, LLC39,9422.7%−1,631Nov 13, 2026
Vanguard25,9861.8%+8,767Nov 13, 2026
Citadel19,6951.3%newNov 16, 2026
Boothbay Fund Management, LLC13,5240.92%no changeNov 16, 2026
Tower Research Capital LLC (TRC)1500.01%−649Nov 16, 2026
UBS130<0.01%−1,331Nov 10, 2026
Fidelity26<0.01%newNov 10, 2026
Barrett & Company, Inc.8<0.01%no changeOct 22, 2026

CNS Pharmaceuticals, Inc. insider trades